Shares of RxSight Inc. (Nasdaq: RXST) rose 21% in after-hours trading after reporting second-quarter results that topped analysts’ expectations.
The shares climbed to $49.30 after ending the regular session at $40.78 and a $1.6 billion market cap.
The Aliso Viejo-based maker of implantable lenses that can be customized after cataract surgery reported revenue surged 68% to $34.9 million while its loss per share was 16 cents. Analysts on average expected a loss of 22 cents on revenue of $32.3 million.
“We continued to make significant progress in the adoption of adjustability as a new standard in the premium market,” Chief Executive Ron Kurtz said in a statement.
For more details, see the Aug. 12 print issue of the Business Journal.
